Targeted activation of diverse CRISPR-Cas systems for mammalian genome editing via proximal CRISPR targeting

Таргетная активация различных систем CRISPR-Cas для редактирования генома млекопитающих посредством проксимального CRISPR-таргетинга
Xiao Lan Ding, Yanfang Jiang, Gregory D. Davis, Fuqiang Chen, Yongmei Feng, Timothy Seebeck
2017-04-07

FnCas9 (type II-B)chromatin microenvironmentsmammalian genome editingproximal CRISPR targetingproxy-CRISPRtype II-C Cas9type V Cpf1
Bacterial CRISPR-Cas systems comprise diverse effector endonucleases with different targeting ranges, specificities and enzymatic properties, but many of them are inactive in mammalian cells and are thus precluded from genome-editing applications. Here we show that the type II-B FnCas9 from Francisella novicida possesses novel properties, but its nuclease function is frequently inhibited at many genomic loci in living human cells. Moreover, we develop a proximal CRISPR (termed proxy-CRISPR) targeting method that restores FnCas9 nuclease activity in a target-specific manner. We further demonstrate that this proxy-CRISPR strategy is applicable to diverse CRISPR-Cas systems, including type II-C Cas9 and type V Cpf1 systems, and can facilitate precise gene editing even between identical genomic sites within the same genome. Our findings provide a novel strategy to enable use of diverse otherwise inactive CRISPR-Cas systems for genome-editing applications and a potential path to modulate the impact of chromatin microenvironments on genome modification.
1
A proximal CRISPR method called proxy-CRISPR restores FnCas9 nuclease activity in a target-specific manner.
2
Proxy-CRISPR facilitates precise gene editing even between identical genomic sites within the same genome.
3
Proxy-CRISPR provides a strategy to enable use of otherwise inactive CRISPR-Cas systems and to modulate chromatin microenvironment impacts on genome modification.
4
The proxy-CRISPR strategy is applicable to diverse CRISPR-Cas systems, including type II-C Cas9 and type V Cpf1.
5
The type II-B FnCas9 from Francisella novicida has novel properties but its nuclease function is frequently inhibited at many genomic loci in human cells.

Diverse CRISPR-Cas systems (including type II-B FnCas9, type II-C Cas9, and type V Cpf1) deployed for mammalian genome editing

Proximal CRISPR (proxy-CRISPR) targeting method to restore or enable nuclease activity and facilitate precise, target-specific genome editing across otherwise inactive CRISPR-Cas systems in human cells, and modulation of chromatin microenvironment impacts

Publication Details
Publication Date
2017-04-07
Journal
Publisher
ISSN
Cited by
156
Access Type
Author Information
Authors
Xiao Lan Ding
Yanfang Jiang
Gregory D. Davis
Fuqiang Chen
Yongmei Feng
Timothy Seebeck
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%